CDR1as is upregulated in CDDP-resistant NSCLC cells, whereas its overexpression enhances the stemness signatures (SOX2, OCT4, and Nanog) via the miR-641/HOXA9 axis and confers resistance to CDDP-sensitive NSCLC cells (191). The gene discussed is SOX2; the disease is non-small cell lung carcinoma.